Home-based Exercise Training for COPD Patients (HOMEX-2)

December 23, 2021 updated by: University of Zurich

Effects of a Long-term Home-based Exercise Training Program Using Minimal Equipment vs Usual Care in COPD Patients: A Multicenter Randomized Controlled Trial

The aim of this study is to assess the effectiveness of a home-based exercise training program in COPD patients who did not participate in an inpatient or outpatient rehabilitation program within the last 2 years.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Exercise training is an important component of pulmonary rehabilitation (PR) the management of chronic obstructive pulmonary disease (COPD) and numerous trials have shown large improvements in health-related quality of life (HRQoL) and exercise capacity in persons with COPD. However, the great majority of patients who would benefit from PR never follow such a program. Moreover, many COPD patients are either not instructed to exercise at all or fail to adhere to exercise training at home after completing PR.

This study evaluates a newly developed exercise training program that requires minimal equipment (i.e., only a chair and elastic bands) and can be easily implemented long-term in the patient's home-setting.

Study Type

Interventional

Enrollment (Actual)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Zurich, Switzerland, 8001
        • University of Zurich

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Signed informed consent after being informed
  • Diagnosis of COPD, defined as forced expiratory volume in 1s/forced vital capacity (FEV1/FVC)<70% predicted, FEV1<80 % predicted after bronchodilation, with or without chronic symptoms (cough, sputum production) corresponding to a GOLD stage II-IV
  • No participation in an inpatient or outpatient pulmonary rehabilitation within the last 12 months
  • Male and female patients ≥40 years of age
  • Knowledge of German language to understand study material and assessments

Exclusion Criteria:

  • Patients not able to conduct the exercise training program due to physical, cognitive or safety reasons, as judged by investigator; e.g., lower limb joint surgery within preceding 3 months, unstable cardiac disease, predominant neurological limitations.
  • Planned participation in a pulmonary rehabilitation program

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: OTHER
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Exercise intervention
Home-based, minimal equipment exercise training program.
Home-based exercise training program that requires only minimal equipment, and is individually adaptable to the participant's exercise level (6 times per week; 15-20 min; 38 exercise cards and one interactive training agenda booklet). After randomization, a health care professional (HOMEX coach) will visit the intervention group participants at their home to set up the training location, to instruct the exercises and to establish individualized goals. Follow-up visits are planned after 3 and 8-9 weeks. Regular telephone calls will be conducted by the same HOMEX coach to motivate the patients, to discuss training progress and concrete benefits and barriers, and to adapt goals and the training program. Additional intervention elements are that a relative or friend is involved as a "sparring" partner to support the participant. The general practitioner is informed about the participation of his/her patient in the intervention.
NO_INTERVENTION: Control
Usual care (study participation does not have any impact on regular treatment decisions, including participation in other exercise training programs).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Dyspnea (Chronic Respiratory Questionnaire (CRQ) domain)
Time Frame: Change from baseline to 12 months
Dyspnea domain of the CRQ; 5 questions; 7-point Likert-type scale ranging from 1 (most severe dyspnea) to 7 (no dyspnea)
Change from baseline to 12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Dyspnea (Chronic Respiratory Questionnaire (CRQ) domain)
Time Frame: Change from baseline to 3, 6 and 12 months
Dyspnea domain of the CRQ; 5 questions; 7-point Likert-type scale ranging from 1 (most severe dyspnea) to 7 (no dyspnea)
Change from baseline to 3, 6 and 12 months
Functional exercise capacity (Six-Minute Walk Test; 6MWT)
Time Frame: Change from baseline to 12 months
Total distance in meters walked by the patient during timed six minutes. The 6MWT will be conducted twice (the better result will be used) and according to the American Thoracic Society (ATS) guidelines
Change from baseline to 12 months
Functional exercise capacity (1-min Sit-to-Stand test; 1-min-STS test)
Time Frame: Change from baseline to 12 months
The number of repetitions that the patient completes the full sit-to-stand movement from a standard chair (i.e. standing up from a chair and sitting down again) during one minute
Change from baseline to 12 months
Health-related quality of life (Chronic Respiratory Questionnaire; CRQ)
Time Frame: Change from baseline to 12 months
Remaining domains of the CRQ (besides the dyspnea domain): Domains fatigue, emotional function and mastery. The total CRQ contains 20 questions responded to on a 7-point Likert-type scale, ranging from 1 to 7 with lower scores indicating worse HRQoL, loading on the domains dyspnea, fatigue, emotional and mastery
Change from baseline to 12 months
Physical activity (PROactive physical activity in COPD instrument, clinical visit version; C-PPAC; domains amount and difficulty)
Time Frame: Change from baseline to 12 months, measured during 1 week prior to the visits
The C-PPAC is a validated and reliable hybrid tool combining a short patient-reported outcome questionnaire and two activity monitor variables (assessed by the accelerometer ActiGraph®) to measure physical activity in COPD patients in the two domains amount and difficulty (item scores 0-4, scale 0-100)
Change from baseline to 12 months, measured during 1 week prior to the visits
Symptoms (COPD Assessment Test; CAT)
Time Frame: Change from baseline to 12 months
The CAT measures the impact of COPD on a person's health status (8 questions, 6-point Likert-type scale)
Change from baseline to 12 months
Hospital Anxiety and Depression Scale (HADS)
Time Frame: Change from baseline to 12 months
Symptoms of depression and anxiety (14 questions, 4-point Likert-type scale)
Change from baseline to 12 months
Health status (Feeling Thermometer; FT)
Time Frame: Change from baseline to 12 months
The FT is a visual analogue scale for overall health state ranging from 0 (worst health you can imagine) to 100 (best healthy you can imagine)
Change from baseline to 12 months
Health-related quality of life (EuroQOL; EQ-5D-5L)
Time Frame: Change from baseline to 12 months
The EQ-5D-5L assesses the 5 dimensions mobility, self-care, usual activities, pain/discomfort, anxiety/depression including 1 item with 5 levels each
Change from baseline to 12 months
Exacerbations of COPD (event based, patient reported)
Time Frame: During the entire study, assessed at 3, 6 and 12 months
The event-based definition required an increase in symptoms and an increase in dosage of or new prescription of systemic corticosteroids and/or antibiotics
During the entire study, assessed at 3, 6 and 12 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Compliance to the exercise training program
Time Frame: Assessed daily by intervention group participants during 12 months
Percentage of fulfilled training sessions based on training diaries
Assessed daily by intervention group participants during 12 months
Satisfaction with the exercise training program (self-developed questionnaire)
Time Frame: From baseline to 12 months, assessed at 12 months
Self-developed questionnaire assessing satisfaction with the intervention: 10 specific questions regarding elements of the intervention using Likert-type scales from 0=not useful at all to 10=very useful) and 4 global questions using Likert-type scales (from 0=worst outcome to 4=best outcome)
From baseline to 12 months, assessed at 12 months
Experience with the exercise training program of the participants
Time Frame: From baseline to 12 months, assessed at 12 months
Semi-structured interview and/or focus groups
From baseline to 12 months, assessed at 12 months
Experience with the exercise training program of the health professionals
Time Frame: From baseline to 12 months, assessed at 12 months
Semi-structured interview and/or focus groups
From baseline to 12 months, assessed at 12 months
Cost effectiveness
Time Frame: From baseline to 12 months, assessed at 3, 6 and 12 months
Questionnaire: Cost per quality-adjusted life-year, direct healthcare costs, direct non-healthcare costs, indirect costs
From baseline to 12 months, assessed at 3, 6 and 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

October 19, 2018

Primary Completion (ACTUAL)

March 10, 2021

Study Completion (ACTUAL)

December 15, 2021

Study Registration Dates

First Submitted

July 17, 2018

First Submitted That Met QC Criteria

August 29, 2018

First Posted (ACTUAL)

August 31, 2018

Study Record Updates

Last Update Posted (ACTUAL)

December 27, 2021

Last Update Submitted That Met QC Criteria

December 23, 2021

Last Verified

December 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Lung Diseases, Obstructive

Clinical Trials on Exercise

3
Subscribe